Keyword: AstraZeneca

News

Merck & Co Analyst Pleads Guilty to Insider Trading

23.02.2015 - A former New York-based financial analyst who followed the pharmaceutical industry and is believed to have been employed by Merck & Co has pleaded guilty to participating in an...

News

Pfizer Set to Acquire Hospira for $15 Billion

06.02.2015 - Pfizer Set to Acquire Hospira for $15 Billion In its first major deal since the collapse of its effort to buy AstraZeneca last year, US drugmaker Pfizer has announced that it will...

News

US Ends Probe Into AstraZeneca’s Brilinta Without Charges

21.08.2014 - The US Department of Justice has closed without charges its ten-month investigation of British-Swedish AstraZeneca revolving around the blood thinner Brilinta. The probe into what...

News

Shire to Bow to AbbVie's Sweetened $53 Billion Offer

15.07.2014 - Dublin-based pharmaceutical producer Shire, a specialist in drugs to treat rare diseases, has succumbed to an increased £31 billion ($53 billion) takeover offer from US drugmaker...

News

AbbVie Hikes Bid for Shire to $51 Billion

09.07.2014 - US drugmaker AbbVie has raised its offer for London-based pharmaceutical producer Shire to £30.1 billion ($51.3 billion), hoping to win over its reluctant target after three...

News

Pfizer-AstraZeneca Deal Still Occupies Analysts’ Fantasy

16.06.2014 - The world's biggest would-be drugs merger hit a wall last month but speculation about smart ways that Pfizer could yet seal a deal with AstraZeneca remains intense. Even as talks...

News

Benoît Potier Becomes Chairman of ERT

04.06.2014 - Air Liquide CEO and Chairman Benoît Potier succeeded Leif Johansson as chairman of the European Round Table of Industrialists (ERT) on June 1. Potier, who joined Air Liquide in...

News

Novo Nordisk Launches Diabetes Drug in Germany After Rethink

02.06.2014 - Danish drugmaker Novo Nordisk, the world's biggest insulin producer, has decided to launch its diabetes drug Tresiba in Germany after seeing signs of a more favorable pricing...